Kameel D. Farag - Interim CFO at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CFO
Issuer Symbol
AKTX on Nasdaq
All Insider Reports
All Insider Reports

Kameel D. Farag - trading volume in the past year for Akari Therapeutics Plc

Holdings reported by Kameel D. Farag for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 26,619 $19,964 $0.7500 01 Nov 2025 Direct
Pre-Funded Warrants to purchase ADRs 24,745 $9,999 $0.4041 16 Dec 2025 Direct American Depositary Shares representing Ordinary Shares
Warrants to purchase American Depositary Shares ("ADRs") 24,745 16 Dec 2025 Direct American Depositary Shares representing Ordinary Shares

Transactions reported by Kameel D. Farag for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.